Lersch C - Search Results

1

Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinoma.

von Delius S, Ayvaz M, Wagenpfeil S, Eckel F, Schmid RM, Lersch C. von Delius S, et al. Among authors: lersch c. Thromb Haemost. 2007 Aug;98(2):434-9. Thromb Haemost. 2007. PMID: 17721628

2

Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.

von Delius S, Lersch C, Schulte-Frohlinde E, Mayr M, Schmid RM, Eckel F. von Delius S, et al. Among authors: lersch c. BMC Cancer. 2005 Jun 12;5:61. doi: 10.1186/1471-2407-5-61. BMC Cancer. 2005. PMID: 15949047 Free PMC article. Clinical Trial.

3

Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinoma.

Eckel F, Schmelz R, Erdmann J, Mayr M, Lersch C. Eckel F, et al. Among authors: lersch c. Cancer Invest. 2003;21(5):690-4. doi: 10.1081/cnv-120023767. Cancer Invest. 2003. PMID: 14628426 Clinical Trial.

4

Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study.

von Delius S, Eckel F, Wagenpfeil S, Mayr M, Stock K, Kullmann F, Obermeier F, Erdmann J, Schmelz R, Quasthoff S, Adelsberger H, Bredenkamp R, Schmid RM, Lersch C. von Delius S, et al. Among authors: lersch c. Invest New Drugs. 2007 Apr;25(2):173-80. doi: 10.1007/s10637-006-9010-y. Epub 2006 Sep 13. Invest New Drugs. 2007. PMID: 16983507 Clinical Trial.

5

Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer.

Eckel F, Lersch C, Lippl F, Assmann G, Schulte-Frohlinde E. Eckel F, et al. Among authors: lersch c. J Exp Clin Cancer Res. 2000 Sep;19(3):295-300. J Exp Clin Cancer Res. 2000. PMID: 11144522 Clinical Trial.

6

Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma.

Eckel F, von Delius S, Mayr M, Dobritz M, Fend F, Hosius C, Schleyer E, Schulte-Frohlinde E, Schmid RM, Lersch C. Eckel F, et al. Among authors: lersch c. Oncology. 2005;69(5):363-71. doi: 10.1159/000089990. Epub 2005 Nov 24. Oncology. 2005. PMID: 16319507 Clinical Trial.

7

Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.

von Delius S, Lersch C, Schulte-Frohlinde E, Fend F, Dobritz M, Schmid RM, Eckel F. von Delius S, et al. Among authors: lersch c. Z Gastroenterol. 2006 Jan;44(1):39-42. doi: 10.1055/s-2005-858567. Z Gastroenterol. 2006. PMID: 16397838

8

Capecitabine for treatment of advanced hepatocellular carcinoma.

von Delius S, Lersch C, Mayr M, Stock K, Schulte-Frohlinde E, Schmid RM, Eckel F. von Delius S, et al. Among authors: lersch c. Hepatogastroenterology. 2007 Dec;54(80):2310-4. Hepatogastroenterology. 2007. PMID: 18265654

9

Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: a pilot study.

Eckel F, Lersch C, Assmann G, Schulte-Frohlinde E. Eckel F, et al. Among authors: lersch c. Cancer Invest. 2002;20(2):180-5. doi: 10.1081/cnv-120001144. Cancer Invest. 2002. PMID: 11901537 Clinical Trial.

10

Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis.

Schulte-Frohlinde E, Wagenpfeil S, Willis J, Lersch C, Eckel F, Schmid R, Schusdziarra V. Schulte-Frohlinde E, et al. Among authors: lersch c. J Gastroenterol Hepatol. 2007 Aug;22(8):1241-8. doi: 10.1111/j.1440-1746.2006.04620.x. J Gastroenterol Hepatol. 2007. PMID: 17688664 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page